Valiant Navion™ VNMC2822C207TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC2822C207TU VAL NAV CS TP · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000101213), received between Jan 15, 2019 and Mar 13, 2025 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Difficult or Delayed Positioning” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult or Delayed Positioning1
- Leak/Splash1
Patient problems
- Blood Loss1
- Death1
- Insufficient Information1
- Perforation of Vessels1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMar 13, 2025Leak/Splash; Leak/Splash
IT WAS REPORTED THAT A PATIENT WHO WAS TREATED FOR A 45-MILLIMETER ANEURYSM WITH A VALIANT NAVION STENT GRAFT EXPERIENCED A PROXIMAL AND DISTAL ENDOLEAK. THE EVENT WAS DISCOVERED ON THE DATE OF A CT SCAN PERFORMED APPROXIMATELY 4 YEARS AND 9 MONTHS POST-INDEX PROCEDURE. DEGENERATION OF THE AORTA AT THE PROXIMAL AND DISTAL EDGE OF THE GRAFT WAS ALSO NOTED. THE PATIENT UNDERWENT TREATMENT WITH THE ADDITION OF PROXIMAL AND DISTAL EXTENSIONS USING A STENT GRAFT, RESOLVING THE ENDOLEAK. THE CAUSE OF THE ENDOLEAKS COULD NOT BEDETERMINED BY THE HEALTHCARE PROFESSIONAL. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Insufficient Information
MAUDE report 21596227 ↗DeathJan 15, 2019Difficult or Delayed Positioning; Difficult or Delayed Positioning
AN ATTEMPT WAS MADE TO IMPLANT A VALIANT NAVION STENT GRAFT IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A PAU. THE MINIMUM DIAMETERS OF THE LEFT AND RIGHT ILIAC ARTERIES WERE 4 MM AND 5.4 MM, RESPECTIVELY. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE, THE PHYSICIAN DILATED THE RIGHT ILIAC ARTERY WITH A BALLOON AND ADVANCED AN 18 FR AND A 20 FR NON-MEDTRONIC SHEATH. THE PHYSICIAN THEN ATTEMPTED TO DELIVER THE NAVION DEVICE, HOWEVER IT COULD NOT PASS THROUGH THE ILIAC ARTERY. AFTER RETRIEVING THE NAVION DEVICE FROM THE ILIAC, THE PHYSICIAN NOTICED EXTRAVASATION IN THE ILIAC, INDICATING THERE WAS A TEAR IN THE ARTERY. THE PHYSICIAN REPAIRED THIS WITH A NON-MEDTRONIC STENT. IT WAS ALSO NOTED THAT THE ILIAC WAS LEAKING DISTAL TO THIS TEAR AND THE PHYSICIAN CARRIED OUT A SURGICAL REPAIR. AFTER REPAIRING THE DISTAL TEAR, THE PHYSICIAN ATTEMPTED TO ADVANCE THE NON-MEDTRONIC (GORE) 20 FR DRY SEAL SHEATH AND IT TORE THE ARTERY IN HALF. THE PHYSICIAN THEN REPAIRED THIS TEAR SURGICALLY AND ALSO PERFORMED A BI-FEMORAL BYPASS DUE TO THE FRAGILE NATURE OF THE PATIENT'S AORTA AND THE DIFFICULTY IN REPAIRING THE TEAR. THE PATIENT LOST A LARGE AMOUNT OF BLOOD DURING THE SURGICAL OPERATION AND
Patient problems: Blood Loss; Death; Perforation of Vessels
MAUDE report 8247452 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page